Cargando…
Natural products as LSD1 inhibitors for cancer therapy
Natural products generally fall into the biologically relevant chemical space and always possess novel biological activities, thus making them a rich source of lead compounds for new drug discovery. With the recent technological advances, natural product-based drug discovery is now reaching a new er...
Autores principales: | Fang, Yuan, Yang, Chao, Yu, Zhiqiang, Li, Xiaochuan, Mu, Qingchun, Liao, Guochao, Yu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305746/ https://www.ncbi.nlm.nih.gov/pubmed/32837872 http://dx.doi.org/10.1016/j.apsb.2020.06.007 |
Ejemplares similares
-
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
por: Fang, Yuan, et al.
Publicado: (2019) -
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
por: Fang, Yuan, et al.
Publicado: (2020) -
LSD: a leaf senescence database
por: Liu, Xiaochuan, et al.
Publicado: (2011) -
Antitumor activity of LSD1 inhibitors in lung cancer
por: Mohammad, Helai P., et al.
Publicado: (2016) -
Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors
por: Shi, Ying, et al.
Publicado: (2018)